Literature DB >> 19805936

A 5-year review of maternal mortality associated with eclampsia in a tertiary institution in northern Nigeria.

Abubakar Ali Kullima1, Mohammed Bello Kawuwa, Bala Mohammed Audu, Hadiza Usman, Ado Danazumi Geidam.   

Abstract

OBJECTIVE: To determine the incidence of maternal mortality associated with eclampsia and to determine how socio-demographic and clinical characteristics of the women influence the deaths.
METHODOLOGY: Records of 52 eclampsia-related mortalities from January 2003 to December 2007 were reviewed, retrospectively. Their social demography, mode and place of delivery, time of eclampsia, and fetal outcome were extracted for analysis.
RESULTS: Eclampsia accounted for 52 (46.4%) of the 112 total maternal deaths recorded within the 5-year period, with case fatality of 22.33%. Age group <20, 20-29 and above 30 all had similar case fatality rate of 22.1%, 23.8% and 26.7%, respectively. Those who were experiencing their first deliveries have the worst deaths recording 42.5% of the case fatality in that category. As expected, unbooked had a higher case fatality of 24.0% compared to 15% among book cases, while those with formal education also had more death (22.3% case fatality) as compared to 3.3% among those who had some form of formal education. Antepartum eclampsia was the cause in 50% of the death, 11 (21.2%) of the pregnancies were not delivered before their death, while 18 (34.6%) were stillbirth.
CONCLUSION: Eclampsia still remains the major cause of maternal mortality in this region resulting from unsupervised pregnancies and deliveries. There is need to educate and encourage the general public for antenatal care and hospital delivery.

Entities:  

Mesh:

Year:  2009        PMID: 19805936     DOI: 10.4103/1596-3519.56233

Source DB:  PubMed          Journal:  Ann Afr Med        ISSN: 0975-5764


  11 in total

1.  Maternal and fetal outcomes after introduction of magnesium sulphate for treatment of preeclampsia and eclampsia in selected secondary facilities: a low-cost intervention.

Authors:  Jamilu Tukur; Babatunde Ahonsi; Salisu Mohammed Ishaku; Idowu Araoyinbo; Ekechi Okereke; Ayodeji Oginni Babatunde
Journal:  Matern Child Health J       Date:  2013-09

2.  Predictors of extra care among magnesium sulphate treated eclamptic patients at Muhimbili National Hospital, Tanzania.

Authors:  Projestine S Muganyizi; Mohammed S Shagdara
Journal:  BMC Pregnancy Childbirth       Date:  2011-06-03       Impact factor: 3.007

3.  Factors influencing the use of magnesium sulphate in pre-eclampsia/eclampsia management in health facilities in Northern Nigeria: a mixed methods study.

Authors:  Olugbenga Oguntunde; Zulfiya Charyeva; Molly Cannon; William Sambisa; Nosakhare Orobaton; Ibrahim A Kabo; Kamil Shoretire; Saba'atu E Danladi; Nurudeen Lawal; Habib Sadauki
Journal:  BMC Pregnancy Childbirth       Date:  2015-06-03       Impact factor: 3.007

4.  Maternal mortality predictors in women with hypertensive disorders of pregnancy: a retrospective cohort study.

Authors:  Yifru Berhan; Gezahegn Endeshaw
Journal:  Ethiop J Health Sci       Date:  2015-01

Review 5.  Maternal death and obstetric care audits in Nigeria: a systematic review of barriers and enabling factors in the provision of emergency care.

Authors:  Julia Hussein; Atsumi Hirose; Oluwatoyin Owolabi; Mari Imamura; Lovney Kanguru; Friday Okonofua
Journal:  Reprod Health       Date:  2016-04-22       Impact factor: 3.223

6.  Risk factors for maternal mortality associated with eclampsia presenting at a Nigerian tertiary hospital.

Authors:  Kabiru Afolarin Rabiu; Adeniyi Abiodun Adewunmi; Tawakwalit Abimbola Ottun; Fatimat Motunrayo Akinlusi; Adewunmi Adeoye Adebanjo; Taiwo Ganiyat Alausa
Journal:  Int J Womens Health       Date:  2018-11-06

7.  Prevalence of hypertensive disorders of pregnancy and pregnancy outcomes in Sub-Saharan Africa: A systematic review and meta-analysis.

Authors:  Kasiye Shiferaw Gemechu; Nega Assefa; Bizatu Mengistie
Journal:  Womens Health (Lond)       Date:  2020 Jan-Dec

8.  Quality medicines in maternal health: results of oxytocin, misoprostol, magnesium sulfate and calcium gluconate quality audits.

Authors:  Chimezie Anyakora; Yetunde Oni; Uchenna Ezedinachi; Adebola Adekoya; Ibrahim Ali; Charles Nwachukwu; Charles Esimone; Victor Abiola; Jude Nwokike
Journal:  BMC Pregnancy Childbirth       Date:  2018-01-30       Impact factor: 3.007

9.  Maternal death review and outcomes: An assessment in Lagos State, Nigeria.

Authors:  Friday Okonofua; Donald Imosemi; Brian Igboin; Adegboyega Adeyemi; Chioma Chibuko; Adewale Idowu; Wilson Imongan
Journal:  PLoS One       Date:  2017-12-14       Impact factor: 3.240

10.  Outcome of multifaceted interventions for improving the quality of antenatal care in Nigerian referral hospitals.

Authors:  Friday Ebhodaghe Okonofua; Lorretta Favour Chizomam Ntoimo; Bola Ekezue; Victor Ohenhen; Kingsley Agholor; Mohammed Gana; Brian Igboin; Chioma Ekwo; Wilson Imongan; Hadiza Galadanci; Rosemary Ogu
Journal:  Reprod Health       Date:  2020-11-04       Impact factor: 3.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.